ATE333502T1 - Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen - Google Patents

Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen

Info

Publication number
ATE333502T1
ATE333502T1 AT99972677T AT99972677T ATE333502T1 AT E333502 T1 ATE333502 T1 AT E333502T1 AT 99972677 T AT99972677 T AT 99972677T AT 99972677 T AT99972677 T AT 99972677T AT E333502 T1 ATE333502 T1 AT E333502T1
Authority
AT
Austria
Prior art keywords
nucleic acid
recombination
polypeptide
methods
replication
Prior art date
Application number
AT99972677T
Other languages
English (en)
Inventor
Andrew Raymon Morton Bradbury
Daniele Sblattero
Original Assignee
S I S S A Scuola Internaz Supe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I S S A Scuola Internaz Supe filed Critical S I S S A Scuola Internaz Supe
Application granted granted Critical
Publication of ATE333502T1 publication Critical patent/ATE333502T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Ceramic Products (AREA)
AT99972677T 1998-11-19 1999-11-18 Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen ATE333502T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002509A IT1303776B1 (it) 1998-11-19 1998-11-19 Processo per la preparazione di genoteche, di polipeptidi utilizzandodette genoteche e i polipepti ottenuti.

Publications (1)

Publication Number Publication Date
ATE333502T1 true ATE333502T1 (de) 2006-08-15

Family

ID=11381090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972677T ATE333502T1 (de) 1998-11-19 1999-11-18 Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen

Country Status (9)

Country Link
EP (1) EP1131421B1 (de)
AT (1) ATE333502T1 (de)
AU (1) AU3790300A (de)
CA (1) CA2350779A1 (de)
DE (1) DE69932446T2 (de)
ES (1) ES2268907T3 (de)
IL (2) IL143123A0 (de)
IT (1) IT1303776B1 (de)
WO (1) WO2000031246A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780620B1 (en) 1998-12-23 2004-08-24 Bristol-Myers Squibb Company Microbial transformation method for the preparation of an epothilone
US6686154B2 (en) 2000-06-05 2004-02-03 Zyomyx, Inc. Screening of phage displayed peptides without clearing of the cell culture
DE60224720D1 (en) * 2001-11-22 2008-03-06 Univ Keio Re
WO2011140254A1 (en) 2010-05-04 2011-11-10 Adimab, Llc Antibodies against epidermal growth factor receptor (egfr) and uses thereof
US8691231B2 (en) 2011-06-03 2014-04-08 Merrimack Pharmaceuticals, Inc. Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
WO2013173582A1 (en) 2012-05-17 2013-11-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis c virus neutralizing antibody
US9751931B2 (en) 2012-10-26 2017-09-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis C virus neutralizing antibodies and methods
TW201833140A (zh) 2017-01-09 2018-09-16 美商莫瑞麥克製藥公司 抗fgfr抗體及使用方法
TWI788340B (zh) 2017-04-07 2023-01-01 美商必治妥美雅史谷比公司 抗icos促效劑抗體及其用途
WO2019075090A1 (en) 2017-10-10 2019-04-18 Tilos Therapeutics, Inc. ANTI-LAP ANTIBODIES AND USES THEREOF
US20210371537A1 (en) 2018-09-18 2021-12-02 Merrimack Pharmaceuticals, Inc. Anti-tnfr2 antibodies and uses thereof
EP3863722A2 (de) 2018-10-10 2021-08-18 Tilos Theapeutics, Inc. Anti-lap-antikörper und verwendungen davon
KR102559149B1 (ko) * 2018-10-26 2023-07-24 에프. 호프만-라 로슈 아게 재조합효소 매개 카세트 교환을 이용한 다중특이적 항체 스크리닝 방법
CN113874083A (zh) 2019-03-01 2021-12-31 梅里麦克制药股份有限公司 抗-tnfr2抗体及其用途
CN113661173B (zh) 2019-03-29 2024-10-01 豪夫迈·罗氏有限公司 通过以限定的组织形式靶向整合多个表达盒来产生表达FcRn的细胞的方法
MX2022012005A (es) * 2020-03-27 2022-10-21 Ddbio Co Ltd Shang Hai Metodo para el despliegue de anticuerpo biespecifico en la superficie de celula de mamifero y vector.
EP4132971A1 (de) 2020-04-09 2023-02-15 Merck Sharp & Dohme LLC Affinitätsgereifte anti-lap-antikörper und verwendungen davon
CN117430696A (zh) * 2022-07-22 2024-01-23 北京智仁美博生物科技有限公司 用于表达Fab片段库的重组系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117679A (en) * 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5728557A (en) * 1995-06-01 1998-03-17 Merck & Co., Inc. Method of making herpes simplex type 1 mutants and mutants so produced
EP0948615B1 (de) * 1996-12-20 2004-12-15 Novozymes A/S In vivo rekombination

Also Published As

Publication number Publication date
IT1303776B1 (it) 2001-02-23
CA2350779A1 (en) 2000-06-02
IL143123A (en) 2009-11-18
WO2000031246A2 (en) 2000-06-02
WO2000031246A3 (en) 2000-08-17
DE69932446T2 (de) 2007-01-04
ES2268907T3 (es) 2007-03-16
EP1131421B1 (de) 2006-07-19
AU3790300A (en) 2000-06-13
EP1131421A2 (de) 2001-09-12
DE69932446D1 (de) 2006-08-31
ITMI982509A1 (it) 2000-05-19
IL143123A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
DE69932446D1 (de) Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen
ATE460472T1 (de) Verfahren und zusammensetzungen zur synthese von nukleinsäuremolekülen unter verwendung multipler erkennungsstellen
ATE294229T1 (de) Verfahren zur trocknung von kompetenten zellen
ATE204298T1 (de) Hybrider mensch/tier faktor viii
ATE309342T1 (de) Verfahren zur herstellung in vitro von rekombinierten nucleotidsequenzen, und so hergestelte genbanken und sequenzen
ATE391789T1 (de) Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
DE59708838D1 (de) Spiegelselektion und spiegelevolution von nucleinsäuren
EP0823914A4 (de) Systematische evoultion von liganden durch exponentielle anreicherung: gewebe-selex
ATE272833T1 (de) Verfahren zur erstellung von arrays hoher dichte
DK0586618T3 (da) Anvendelse af nuklainsyreanaloger i diagnostiske og analytiske fremgangsmåder
DE69739304D1 (de) Verfahren und Zusammensetzungen zur Bestimmung von Sequenzen von Nukleinsäure-Molekülen
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
AU2002218166A1 (en) Collections of repeat proteins comprising repeat modules
EP1832567A3 (de) Entwicklung neuer molekularer Funktionen
ATE317899T1 (de) Gefrierschutzproteine aus choristoneura sp., gene und verfahren zu ihrer verwendung
DK1098991T3 (da) Hidtil ukendte fremgangsmåder til identifikation af ligand- og målbiomolekyler
EP1169641A4 (de) Proteomabbau
Orii et al. Total Synthesis of O‐GalNAcylated Antifreeze Glycoprotein using the Switchable Reactivity of Peptidyl‐N‐pivaloylguanidine
DE60233347D1 (de) Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung
ATE522604T1 (de) Verfahren zur herstellung von proteinen durch elektropulsierung
ATE383575T1 (de) Verfahren zur herstellung einer normalisierten genbank aus nukleinsäure-exktrakten von bodenproben und deren verwendung
WO1998042868A3 (en) Screening method for proline-rich proteins
Amato A high-flying fix for ozone loss
ATE480556T1 (de) Neue fluoreszierende proteine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties